Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.17 USD | +1.93% | +9.31% | +92.12% |
04-12 | Transcript : Generation Bio Co. - Special Call | |
03-07 | Needham Cuts Price Target on Generation Bio to $10 From $14, Maintains Buy Rating | MT |
Business Summary
Number of employees: 174
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Genetic Medicines
100.0
%
| 0 | nan % | 6 | 100.0 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | nan % | 6 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 53 | 17-09-30 | |
Matthew Norkunas
DFI | Director of Finance/CFO | 46 | 20-07-21 |
Antoinette Paone
COO | Chief Operating Officer | 46 | 18-09-30 |
Matthew Stanton
CTO | Chief Tech/Sci/R&D Officer | 51 | 17-09-30 |
Maren Killackey
IRC | Investor Relations Contact | - | - |
Yalonda Howze
LAW | General Counsel | 52 | 23-04-04 |
Phillip Samayoa
PRN | Corporate Officer/Principal | 37 | 18-11-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jeff Jonas
BRD | Director/Board Member | 71 | 18-04-30 |
Director/Board Member | 76 | 17-11-30 | |
Jason Rhodes
FOU | Founder | 54 | 15-12-31 |
Charles Rowland
BRD | Director/Board Member | 65 | 18-07-30 |
Chief Executive Officer | 53 | 17-09-30 | |
Anthony Quinn
BRD | Director/Board Member | 62 | 17-11-30 |
Donald Nicholson
BRD | Director/Board Member | 67 | 17-11-30 |
Ronald Cooper
BRD | Director/Board Member | 61 | 21-02-28 |
Director/Board Member | 61 | 17-11-30 | |
Director/Board Member | 41 | 22-07-14 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 66,489,181 | 56,857,102 ( 85.51 %) | 0 | 85.51 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+92.12% | 211M | |
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+6.79% | 14.16B | |
+38.61% | 12.63B |
- Stock Market
- Equities
- GBIO Stock
- Company Generation Bio Co.